232 related articles for article (PubMed ID: 20557286)
1. Electroporation gene therapy preclinical and clinical trials for melanoma.
Heller LC; Heller R
Curr Gene Ther; 2010 Aug; 10(4):312-7. PubMed ID: 20557286
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Daud AI; DeConti RC; Andrews S; Urbas P; Riker AI; Sondak VK; Munster PN; Sullivan DM; Ugen KE; Messina JL; Heller R
J Clin Oncol; 2008 Dec; 26(36):5896-903. PubMed ID: 19029422
[TBL] [Abstract][Full Text] [Related]
3. Cancer electrogene therapy with interleukin-12.
Cemazar M; Jarm T; Sersa G
Curr Gene Ther; 2010 Aug; 10(4):300-11. PubMed ID: 20560875
[TBL] [Abstract][Full Text] [Related]
4. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
5. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer by electrical fields.
Rols MP
Curr Gene Ther; 2010 Aug; 10(4):255. PubMed ID: 20718698
[No Abstract] [Full Text] [Related]
7. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
Li S; Zhang X; Xia X
J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
[TBL] [Abstract][Full Text] [Related]
8. IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial.
Horton HM; Lalor PA; Rolland AP
Methods Mol Biol; 2008; 423():361-72. PubMed ID: 18370214
[TBL] [Abstract][Full Text] [Related]
9. Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice.
Heinzerling L; Dummer R; Pavlovic J; Schultz J; Burg G; Moelling K
Exp Dermatol; 2002 Jun; 11(3):232-40. PubMed ID: 12102662
[TBL] [Abstract][Full Text] [Related]
10. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
11. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model.
Heller L; Merkler K; Westover J; Cruz Y; Coppola D; Benson K; Daud A; Heller R
Clin Cancer Res; 2006 May; 12(10):3177-83. PubMed ID: 16707618
[TBL] [Abstract][Full Text] [Related]
13. Plasmid IL-12 electroporation in melanoma.
Cha E; Daud A
Hum Vaccin Immunother; 2012 Nov; 8(11):1734-8. PubMed ID: 23151447
[TBL] [Abstract][Full Text] [Related]
14. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
Galanis E; Hersh EM; Stopeck AT; Gonzalez R; Burch P; Spier C; Akporiaye ET; Rinehart JJ; Edmonson J; Sobol RE; Forscher C; Sondak VK; Lewis BD; Unger EC; O'Driscoll M; Selk L; Rubin J
J Clin Oncol; 1999 Oct; 17(10):3313-23. PubMed ID: 10506635
[TBL] [Abstract][Full Text] [Related]
16. Electroporation based gene therapy--from the bench to the bedside.
Heller R; Shirley S; Guo S; Donate A; Heller L
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():736-8. PubMed ID: 22254415
[TBL] [Abstract][Full Text] [Related]
17. Plasmid DNA gene therapy by electroporation: principles and recent advances.
Murakami T; Sunada Y
Curr Gene Ther; 2011 Dec; 11(6):447-56. PubMed ID: 22023474
[TBL] [Abstract][Full Text] [Related]
18. In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity.
Heller L; Pottinger C; Jaroszeski MJ; Gilbert R; Heller R
Melanoma Res; 2000 Dec; 10(6):577-83. PubMed ID: 11198480
[TBL] [Abstract][Full Text] [Related]
19. Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma.
Komel T; Bosnjak M; Kranjc Brezar S; De Robertis M; Mastrodonato M; Scillitani G; Pesole G; Signori E; Sersa G; Cemazar M
Bioelectrochemistry; 2021 Oct; 141():107843. PubMed ID: 34139572
[TBL] [Abstract][Full Text] [Related]
20. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]